HS
SWTX
HighVista Strategies’s SpringWorks Therapeutics SWTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-68,758
| Closed | -$3.03M | – | 174 |
|
2025
Q1 | $3.03M | Hold |
68,758
| – | – | 1.17% | 12 |
|
2024
Q4 | $2.48M | Buy |
68,758
+32,906
| +92% | +$1.19M | 0.92% | 29 |
|
2024
Q3 | $1.15M | Sell |
35,852
-15,135
| -30% | -$485K | 0.4% | 97 |
|
2024
Q2 | $1.92M | Hold |
50,987
| – | – | 0.7% | 43 |
|
2024
Q1 | $2.51M | Buy |
+50,987
| New | +$2.51M | 0.89% | 34 |
|
2023
Q3 | – | Sell |
-11,688
| Closed | -$306K | – | 160 |
|
2023
Q2 | $306K | Sell |
11,688
-5,959
| -34% | -$156K | 0.14% | 132 |
|
2023
Q1 | $454K | Sell |
17,647
-17,156
| -49% | -$442K | 0.37% | 75 |
|
2022
Q4 | $905K | Buy |
34,803
+21,915
| +170% | +$570K | 0.54% | 50 |
|
2022
Q3 | $368K | Sell |
12,888
-6,192
| -32% | -$177K | 0.21% | 86 |
|
2022
Q2 | $470K | Buy |
19,080
+11,325
| +146% | +$279K | 0.28% | 77 |
|
2022
Q1 | $438K | Sell |
7,755
-10,115
| -57% | -$571K | 0.28% | 77 |
|
2021
Q4 | $1.11M | Buy |
17,870
+2,276
| +15% | +$141K | 0.88% | 40 |
|
2021
Q3 | $989K | Buy |
15,594
+4,963
| +47% | +$315K | 0.65% | 55 |
|
2021
Q2 | $876K | Buy |
10,631
+962
| +10% | +$79.3K | 0.62% | 30 |
|
2021
Q1 | $711K | Sell |
9,669
-2,743
| -22% | -$202K | 0.53% | 36 |
|
2020
Q4 | $900K | Buy |
12,412
+935
| +8% | +$67.8K | 0.57% | 35 |
|
2020
Q3 | $547K | Buy |
11,477
+828
| +8% | +$39.5K | 0.4% | 40 |
|
2020
Q2 | $447K | Buy |
+10,649
| New | +$447K | 0.37% | 34 |
|